NeuPath Health (TSXV:NPTH) ROE % Adjusted to Book Value : -16.07% (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is NeuPath Health ROE % Adjusted to Book Value?

NeuPath Health's ROE % for the quarter that ended in Mar. 2024 was -6.91%. NeuPath Health's PB Ratio for the quarter that ended in Mar. 2024 was 0.43. NeuPath Health's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was -16.07%.

NeuPath Health ROE % Adjusted to Book Value Historical Data

The historical data trend for NeuPath Health's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NeuPath Health ROE % Adjusted to Book Value Chart

NeuPath Health Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

-23.12

-13.43

-41.45

-1.04

NeuPath Health Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-12.64	3.20	17.03	-14.13	-16.07

Competitive Comparison of NeuPath Health's ROE % Adjusted to Book Value

For the Medical Care Facilities subindustry, NeuPath Health's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NeuPath Health's ROE % Adjusted to Book Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, NeuPath Health's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where NeuPath Health's ROE % Adjusted to Book Value falls into.

NeuPath Health ROE % Adjusted to Book Value Calculation

NeuPath Health's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-0.49%	/	0.47
	=	-1.04%

NeuPath Health's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-6.91%	/	0.43
	=	-16.07%

NeuPath Health ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of NeuPath Health's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

NeuPath Health (TSXV:NPTH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » NeuPath Health Inc (TSXV:NPTH) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

181 Bay Street, Suite 2100, Toronto, ON, CAN, M5J 2T3

Website

https://www.neupath.com

NeuPath Health Inc operates an end-to-end, integrated network of healthcare businesses. It utilizes research, data-driven insights, technology, and interdisciplinary care to help restore function for patients impacted by acute and chronic musculoskeletal conditions, including chronic pain, spinal injuries, sports-related injuries, and concussions. It operates an interdisciplinary network of medical clinics in Ontario and Alberta, in addition to an independent medical assessment business with a national network of healthcare providers. Its medical clinics provide comprehensive assessments and rehabilitation services to clients with chronic pain, musculoskeletal/back injuries, sports-related injuries, and concussions.

Executives

Grant Connelly	Senior Officer
Stephen Lemieux	Senior Officer

NeuPath Health (TSXV:NPTH) Headlines

No Headlines